Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition

Willie M Lüdemann,1 Johannes Kahn,2 Paul Herzler,3 Federico Collettini,1 Lynn J Savic,1 Raphael Mohr,4 Uli Fehrenbach,1 Timo Alexander Auer,1 Bernhard Gebauer,1 Holger Amthauer,3 Gero Wieners5 1Department of Diagnostic and Interventional Radiology, Charité Universitätsmedizin, Berlin, Germany; 2Depa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lüdemann WM, Kahn J, Herzler P, Collettini F, Savic LJ, Mohr R, Fehrenbach U, Auer TA, Gebauer B, Amthauer H, Wieners G
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2026-03-01
Edice:	Journal of Hepatocellular Carcinoma
Témata:	Carcinoma Hepatocellular Survival Analysis Radioembolization Targeted Therapy Sorafenib
On-line přístup:	https://www.dovepress.com/lobar-yttrium-90-radioembolization-with-bsa-based-dosimetry-for-unrese-peer-reviewed-fulltext-article-JHC
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!